Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Real-life effectiveness of dupilumab in patients with mild to moderate bronchial asthma comorbid with CRSwNP
Shunsuke Minagawa, Jun Araya, Naoaki Watanabe, et al.
BMC Pulmonary Medicine (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy
Tobias Albrecht, Martin M. Sailer, Flavia Capitani, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 5, pp. 100780-100780
Open Access | Times Cited: 23
Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP
Cecilia Rosso, Eugenio De Corso, Valerio Conti, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 6, pp. 3017-3023
Open Access | Times Cited: 12
Small airways in asthma: From inflammation and pathophysiology to treatment response
Anastasia Siora, Angelos Vontetsianos, Nikolaos Chynkiamis, et al.
Respiratory Medicine (2024) Vol. 222, pp. 107532-107532
Closed Access | Times Cited: 9
Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature
Marella Reale, Giuseppe Licci, Pietro Orlando, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 10, pp. 5023-5031
Closed Access | Times Cited: 9
Effect of Dupilumab in CRSwNP Sinonasal Outcomes from Real Life Studies: A Systematic Review with Meta-analysis
Miguel Rodriguez-Iglesias, Christian Calvo‐Henríquez, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Impact of Biologic Therapy on the Small Airways Asthma Phenotype
Rory Chan, Brian J. Lipworth
Lung (2022) Vol. 200, Iss. 6, pp. 691-696
Open Access | Times Cited: 25
Impact of biologics on lung hyperinflation in patients with severe asthma
Mauro Maniscalco, Claudio Candia, Cecilia Calabrese, et al.
Respiratory Medicine (2024) Vol. 225, pp. 107578-107578
Closed Access | Times Cited: 5
Long-term effects of dupilumab on chronic rhinosinusitis with nasal polyps: A step towards clinical remission
Mona Al‐Ahmad, Asmaa Ali, Wafaa Talat, et al.
World Allergy Organization Journal (2025) Vol. 18, Iss. 2, pp. 101024-101024
Closed Access
Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis
Daiki Nakashima, Tsuguhisa Nakayama, Shunsuke Minagawa, et al.
Journal of Allergy and Clinical Immunology Global (2025) Vol. 4, Iss. 2, pp. 100412-100412
Open Access
Biological therapy in Chronic rhinosinusitis with nasal polyps
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
Dupilumab improves eosinophilic otitis media associated with eosinophilic chronic rhinosinusitis
Daiki Nakashima, Tsuguhisa Nakayama, Syunsuke Minagawa, et al.
Allergology International (2023) Vol. 72, Iss. 4, pp. 557-563
Open Access | Times Cited: 11
Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics
William W. Busse, Ian Pavord, Shahid Siddiqui, et al.
Journal of Asthma and Allergy (2023) Vol. Volume 16, pp. 411-419
Open Access | Times Cited: 10
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective
Marco Caminati, Matteo Maule, Roberto Benoni, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 390-390
Open Access | Times Cited: 3
Direct comparative study of anti-IgE and anti-IL4Rα therapy effectiveness in patients with severe allergic and mixed bronchial asthma
В. В. Наумова, Е. К. Beltyukov, О. П. Ковтун, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 9, pp. 74-86
Open Access | Times Cited: 3
Real-life effects of dupilumab on airway oscillometry in severe uncontrolled asthma
Rory Chan, Brian J. Lipworth
Annals of Allergy Asthma & Immunology (2023) Vol. 131, Iss. 5, pp. 664-666
Open Access | Times Cited: 7
Comparison between clinical trials and real-world evidence studies on biologics for severe asthma
Francesco Menzella, Andrea Ballarin, Maria Cristina Sartor, et al.
Journal of International Medical Research (2022) Vol. 50, Iss. 11
Open Access | Times Cited: 9
Oscillometry in severe asthma: the state of the art and future perspectives
Francesco Menzella, Leonardo Antonicelli, Marcello Cottini, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 7, pp. 563-575
Closed Access | Times Cited: 4
Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma
Carlo Lombardi, Marcello Cottini, Alvise Berti, et al.
Asthma Research and Practice (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Real-World Efficacy of Biological Therapies in Severe Asthma: A Focus on Small Airways
Josuel Ora, Patrizia De Marco, Enrico Motta, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 19, pp. 5883-5883
Open Access
Effect of budesonide combined with montelukast sodium on pulmonary function parameters and immunoglobulin levels in children with bronchial asthma
Fangfang Chu, Lei Liang, Fuzhe Chen
Allergologia et Immunopathologia (2023) Vol. 51, Iss. 4, pp. 151-157
Open Access | Times Cited: 1
Moderate asthma: burden, mechanisms and therapeutic perspectives
Laura De Ferrari, A Riccio, Fulvio Braido
Current Opinion in Allergy and Clinical Immunology (2023) Vol. 24, Iss. 1, pp. 32-36
Closed Access | Times Cited: 1
Page 1

Scroll to top